Clinical Trials Directory

Trials / Completed

CompletedNCT04767360

Effects of BIONESS in Rehabilitation of Stroke

Short-term Therapeutic Effects of Functional Electrical Stimulation Device Bioness L300 on the Somatosensory Cortical Representation in the Rehabilitation of Patients After Stroke

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
32 (actual)
Sponsor
LMU Klinikum · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

A four-weeks randomized clinical two-period crossover-design study will be conducted. Each patient will be randomized in a two separate consecutive treatment periods (Parallel Group Design). "Group A" will be treated with functional electrical stimulation (FES) and a second "Gruppe B" will be treated without FES for two weeks. After this period Group A and Group B will switched.

Detailed description

Prediction of motor recovery in the upper-limb (UL) / lower-limb (LL) in patients with stroke is generally based on clinical examination. However, according to former studies neurophysiological measures may also have a predictive value. In the acute phase, the combination of the motor score and SEPs are best predictive of outcome. Neurophysiological measures alone are of limited value in predicting long term outcome. However, predictive accuracy is substantially improved through the combined use of both of these measures and clinical variables. A four-weeks randomized clinical two-period crossover-design study will be conducted. Each patient will be randomized in a two separate consecutive treatment periods (Parallel Group Design). "Group A" will be treated with functional electrical stimulation (FES) and a second "Gruppe B" will be treated without FES for two weeks. After this period Group A and Group B will switched.

Conditions

Interventions

TypeNameDescription
DEVICEBioness-300Therapeutic treatment of foot drop with the electrical stimulation device Bioness L300.

Timeline

Start date
2021-02-10
Primary completion
2021-10-19
Completion
2022-12-12
First posted
2021-02-23
Last updated
2023-03-15

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT04767360. Inclusion in this directory is not an endorsement.